News
Annual Top Ten Events
-
Qidu Pharma’s intelligent production project for oral preparations with an annual capacity of 10 billion tablets/granules passed the GMP on-site inspection.
June 17, 2026 -
Zheng Jiaqing was honored as a National Model Worker
June 23, 2026 -
Qidu Pharma was designated as one of the “National Outstanding Excellence-Level Smart Factories”
June 23, 2026 -
Qidu Pharma was included in the “Shandong Top 100 Private Enterprises” series of rankings.
June 23, 2026 -
Qidu Pharma was listed among China’s top 100 pharmaceutical companies by main business revenue.
June 23, 2026 -
Qidu Pharma was recognized as one of China’s “Top 100 Pharmaceutical R&D Enterprises”
June 23, 2026 -
The 10th shareholders’ meeting of Qidu Pharma was convened.
June 23, 2026 -
Eighteen products from Qidu Pharma passed or were deemed to have passed the Consistency Evaluation of the Quality and Efficacy of Generic Drugs.
June 23, 2026 -
Qidu Biopharma was authorized to construct the “Zibo (Qidu) Cell Preparation Center and Tissue Cell Bank”.
June 23, 2026 -
Qidu Pharma became the first company in China to receive approval for an enzymatic synthesis process for L-carnitine API.
June 17, 2026
-
June 09, 2025Director Wu Shifu of Medical Devices Department of Provincial Drug Administration Investigates Qidu Pharma
-
June 07, 2025Qidu Pharmaceutical's Compound Glucose/Electrolyte Craniocerebral Surgery Irrigation Solution becomes the first generic drug approved for market in China
-
June 02, 2025Five Qidu Pharma Products Selected in China's 10th National Drug Procurement Program
-
June 02, 2025The Large-Volume Injection Production Project with an Annual Output of 1 Billion Bottles/Bags Fully Completed and Put into Operation
-
March 31, 2025Professor Qiao Renzhong from Beijing University of Chemical Technology visited Qidu Pharmaceutical for inspection
-
March 08, 2023Completion and GMP Approval of the 3,000-ton-per-year Large-Particle Sodium Bicarbonate API Project
- 1
- 2